PTH and chronic kidney disease: Meanwhile, emerging data from real-world clinical experience with extended-release calcifediol for patients with stage 3 or 4 CKD suggest that it is comparable to active vitamin D analogues for controlling parathyroid hormone levels, with the added benefit of replenishing 25(OH)D [37].